Alfa Chemistry
  • Home
  • LipoSwift LNP Delivery Kits
    • LipoSwift LNP - In Vitro Cell Transfection Kit
    • LipoSwift LNP - In Vitro Gene Editing Kit
    • LipoSwift LNP - In Vivo General Delivery Kit
    • LipoSwift LNP - In Vivo Spleen-Targeting Kit
    • LipoSwift LNP - In Vivo Lung-Targeting Kit
    • LipoSwift LNP - In Vivo Liver-Targeting Kit
    • LipoSwift LNP - In Vivo Skin-Targeting Kit
    • LipoSwift LNP - In Vivo Gene Editing Kit
    • LipoSwift LNP - In Vivo Immune Cell Kit
  • About Us
  • Featured Products
    • Oligonucleotide Synthesis Building Blocks
      • 3'-Protected Monomers
      • 5'-DMTr-3'-OH Oligomers
      • 3'-Protected Oligomers
      • 3'-Phosphoramidite Oligomers
    • Cyclic Dinucleotides
    • GalNAc
  • Product Center
    • Raw Materials
      • Oligonucleotides
        • ASOs
        • siRNAs
        • miRNAs
        • Aptamers
        • CpG Oligonucleotides
      • Polymers and Lipids for Drug Delivery
        • Cholesterol
        • Polymers
        • Phospholipids
        • Pegylated Lipids
        • Cationic Lipids
        • Fluorescent Lipids
      • Nucleosides and Nucleotides
        • Nucleosides and Their Analogs
        • Nucleotides and Their Analogs
        • Phosphoramidites
    • Developing Products
      • For Rare Diseases
      • For Liver Diseases
      • For Eye Diseases
      • For Cardiovascular Diseases
      • For Cancers
  • Service Center
    • ASO Development
    • siRNA Development
    • miRNA Development
    • Aptamer Development
    • DNAzyme Development
    • CpG Oligonucleotide Development
    • TF Decoy Technology Development
    • Oligonucleotide Synthesis Services
  • Technology Platforms
    • Featured LNP-based Delivery Platforms
      • Extrahepatic Delivery Platform
      • Gene Editing Platform
      • Antibody-LNP Conjugates Platform
      • In Vivo CAR-T Platform
    • Oligonucleotide Synthesis
      • Solid Phase Oligonucleotide Synthesis
      • Liquid Phase Oligonucleotide Synthesis
        • PEG-Based Liquid Phase Synthesis
        • Non-Polymeric Anchor-Assisted Synthesis
      • Liquid-Solid Coupled Synthesis
    • Nonclinical Evaluation
      • Pharmacodynamic Study
      • Pharmacokinetic Study
      • Safety Evaluation
        • Genotoxicity Evaluation
        • Immunotoxicity Evaluation
        • Reproductive Toxicity Evaluation
        • Safety Pharmacology Evaluation
    • Delivery Systems
      • Lipid Conjugate-Based Delivery Systems
      • GalNAc Conjugate-Based Delivery Systems
      • Polymeric Nanoparticle-Based Delivery Systems
      • Peptide Conjugate-Based Delivery Systems
      • DNA Nanostructure-Based Delivery Systems
      • Antibody Conjugate-Based Delivery Systems
      • Small Molecule Conjugate-Based Delivery Systems
    • Chemical Modification
      • Backbone Modification
      • Furanose Sugar Modification
      • Nucleobase Modification
    • Sequence Design
    • Purification and Analysis
  • Resources
  • Contact Us
miRNA Inhibitors
  • Home
  • Product Center
  • Raw Materials
  • Oligonucleotides
  • miRNAs
  • miRNA Inhibitors
Product Center
  • Raw Materials
    • Oligonucleotides
      • ASOs
      • siRNAs
      • miRNAs
        • miRNA Inhibitors
        • miRNA Mimics
      • Aptamers
      • CpG Oligonucleotides
    • Polymers and Lipids for Drug Delivery
      • Cholesterol
      • Polymers
      • Phospholipids
      • Pegylated Lipids
      • Cationic Lipids
      • Fluorescent Lipids
    • Nucleosides and Nucleotides
      • Nucleosides and Their Analogs
      • Nucleotides and Their Analogs
      • Phosphoramidites
  • Developing Products
    • For Rare Diseases
    • For Liver Diseases
    • For Eye Diseases
    • For Cardiovascular Diseases
    • For Cancers
Contact Us
Alfa Chemistry

Tel:

Fax:

Email:

Address:

miRNA Inhibitors

Catalog Name Inquiry
ONT1802 hsa-miR-3120-5p inhibitor Inquiry
ONT1803 hsa-miR-3121-3p inhibitor Inquiry
ONT1804 hsa-miR-3121-5p inhibitor Inquiry
ONT1805 hsa-miR-3122 inhibitor Inquiry
ONT1806 hsa-miR-297 inhibitor Inquiry
ONT1807 hsa-miR-298 inhibitor Inquiry
ONT1808 hsa-miR-299-3p inhibitor Inquiry
ONT1809 hsa-miR-299-5p inhibitor Inquiry
ONT1810 hsa-miR-29a-5p inhibitor Inquiry
ONT1811 hsa-miR-29b-2-5p inhibitor Inquiry
ONT1812 hsa-miR-29c-5p inhibitor Inquiry
ONT1813 hsa-miR-300 inhibitor Inquiry
ONT1814 hsa-miR-301a-3p inhibitor Inquiry
ONT1815 hsa-miR-301a-5p inhibitor Inquiry
ONT1816 hsa-miR-302a-3p inhibitor Inquiry
ONT1817 hsa-miR-302a-5p inhibitor Inquiry
ONT1818 hsa-miR-302b-5p inhibitor Inquiry
ONT1819 hsa-miR-302d-3p inhibitor Inquiry
ONT1820 hsa-miR-2681-5p inhibitor Inquiry
ONT1821 hsa-miR-2682-3p inhibitor Inquiry
  • First
  • «
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • »
  • Last

Our products and services are for research use only and cannot be used for any clinical purposes.

Alfa Chemistry

As a specialist in oligonucleotide therapeutics, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

Home

About Us

Product Center

Service Center

Technology Platforms

Resources

Contact Us

HEADQUARTERS

Tel:

Fax:

Email:

FOLLOW US

Interested in our products & services? Need detailed information?

Privacy Policy | Cookie Policy | Copyright © 2025 Alfa Chemistry. All rights reserved.